HLK Biotech Holding Group, Inc. (AMHD)

HLK Biotech Holding Group Balance Sheet

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	FY 1999	FY 1998
Period Ending	Jun 30, 1999	Jun 30, 1998
Cash & Equivalents	0.06	0
Cash & Short-Term Investments	0.06	0
Cash Growth	7184.71%	-
Receivables	0	-
Prepaid Expenses	0.07	0.06
Other Current Assets	0.03	-
Total Current Assets	0.17	0.06
Property, Plant & Equipment	0.09	-
Long-Term Investments	0	-
Goodwill	0.6	-
Other Long-Term Assets	0	-
Total Assets	0.85	0.06
Accrued Expenses	0.28	0.02
Short-Term Debt	0.7	0.03
Current Portion of Long-Term Debt	0.1	-
Total Current Liabilities	1.08	0.04
Long-Term Debt	0.4	-
Total Liabilities	1.48	0.04
Common Stock	0.02	0.02
Additional Paid-In Capital	0.48	0.09
Retained Earnings	-1.12	-0.08
Shareholders' Equity	-0.62	0.02
Total Liabilities & Equity	0.85	0.06
Total Debt	1.2	0.03
Net Cash (Debt)	-1.13	-0.02
Working Capital	-0.91	0.02
Tangible Book Value	-1.22	0.02
Machinery	0.09	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.